Inexium (Esomeprazole)

Esomeprazole acts by binding irreversibly to the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the surface of parietal cells. This inhibition blocks the final step of acid secretion, resulting in a sustained increase in gastric pH and a reduction in both basal and stimulated gastric acid output.

The appropriate dose of Inexium is determined by the prescribing healthcare professional based on the specific indication, severity of the condition, patient age, renal function, and any concomitant therapies. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Current data do not show a clear teratogenic risk for esomeprazole, but it should only be used during pregnancy or lactation when clearly needed and after a risk‑benefit assessment by the prescriber. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their healthcare provider.

To order Inexium, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Inexium (esomeprazole) is the S‑enantiomer of omeprazole and often provides more consistent plasma concentrations and a slightly higher acid‑suppression profile. Compared with other PPIs such as lansoprazole or pantoprazole, it may achieve faster healing in some patients, but overall efficacy and safety are comparable across the class.

Inexium tablets should be stored at ambient temperature, preferably below 25 °C (77 °F). Keep the product in its original container, protect it from moisture and direct light, and avoid storing it in areas with high humidity or temperature fluctuations.

Inexium is taken orally, usually as a whole tablet swallowed with a glass of water. It is generally recommended to take the medication before a meal, often in the morning, but patients should follow the specific timing instructions provided by their prescriber.

Serious risks, although uncommon, include severe allergic reactions (rash, swelling, breathing difficulty), Clostridioides difficile‑associated diarrhea, low magnesium levels leading to muscle cramps or cardiac arrhythmias, and an increased risk of bone fractures with long‑term use. Any unusual symptoms should be reported to a healthcare professional promptly.

Inexium should be avoided in individuals with known hypersensitivity to esomeprazole or any component of the formulation. Caution is also advised for patients with severe liver disease, those taking certain interacting medications such as ketoconazole or atazanavir, and patients who have a history of unexplained fractures or low magnesium levels.